VANCOUVER, BC, Aug. 19,
2022 /CNW/ - Franchise Global Health Inc.
("Franchise Global" or the "Company") (TSX-V: FGH)
(FRA: WV4A) plans to release its second quarter financial results
after market close on Friday, August 26,
2022. A conference call hosted by senior management will be
held on Tuesday, August 30, 2022 at
9:00 AM EST.
Telephone Access
Please join the conference call approximately ten minutes prior
to the scheduled start time. Dial-in details for the conference
call are as follows:
• Toronto local
or International: 1-416-915-3239
• Toll-Free (North America):
1-800-319-4610
About Franchise Global
Franchise Global, through its subsidiaries, is a multi-national
operator in the medical cannabis and pharmaceutical industries,
with principal operations in Germany and with operations, assets, strategic
partnerships and investments internationally. Franchise Global's
business objective is to develop a fully‑integrated, leading
European medical cannabis business, with the goal of providing
high-quality pharmaceutical grade medical cannabis to distribution
partners and, ultimately, to patients, at competitive prices.
For more information please visit
www.franchiseglobalhealth.com.
Neither the TSX Venture Exchange nor its Market
Regulator (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
SOURCE Franchise Global Health Inc.